A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
Marie Scully(University College Hospital), Samuel J. Machin(University College London), Beverley J. Hunt(Guy's and St Thomas' NHS Foundation Trust), Ian Longair(University College Hospital), Vickie McDonald(University College London), Hannah Cohen(University College London Hospitals NHS Foundation Trust), Jamie Cavenagh(St Bartholomew's Hospital)
Cited by 420
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
|Critical Care|2016|1.5k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k